Willis Towers Watson Plc Q4 FY2024 earnings call

Management Statement and Operational Highlights

• Strategic Achievements: 2024 was a landmark year with the completion of the 3-year Grow, Simplify and Transform strategy, resulting in 5% organic revenue growth in the fourth quarter, 5% full year organic revenue growth, and adjusted operating margin expansion.
• Client Wins: Highlighted key client wins across segments, leveraging analytics, collaboration, and specialization. For example, a major global logistics provider was signed using industry-leading analytics, and a large global IT vendor's relationship was expanded.
• Portfolio Optimization: Completed the sale of TRANZACT in December 2024, expect this to strengthen growth rates, operating margins, and free cash flow. Reentering the reinsurance market via a joint venture with Bain Capital, and focusing on organic and inorganic investments to improve business mix.

Segment Performance

• Health, Wealth and Career (HWC): Fourth quarter organic revenue grew 3%, excluding TRANZACT it was 6%. Full year organic revenue growth was 4%, excluding TRANZACT it was 5%. HWC's operating margin for the fourth quarter was 41.9% (up 140 basis points year-over-year), and for the full year it was 29.7% (up 170 basis points year-over-year), excluding TRANZACT it was 31.4% (up 180 basis points year-over-year).
• Risk & Broking (R&B): Fourth quarter organic revenue growth was 7%, excluding book of business activity it was 8%. Full year organic revenue growth was 8%. Operating margin for the fourth quarter was 33.5% (up 60 basis points year-over-year).
• Insurance Consulting and Technology (ICT): Fourth quarter revenue was up 11% led by strong technology sales.

Guidance

• Financial Framework: Introduced a framework calling for mid-single-digit organic growth, continued annual adjusted operating margin expansion, annual adjusted EPS growth, and ongoing growth in free cash flow and free cash flow margin.
• 2025 Outlook: Expect mid-single-digit organic growth, continued margin expansion. Plan to allocate approximately $1.5 billion for share repurchases in 2025, subject to market conditions and potential investment in organic and inorganic opportunities. Also, initial investments in the reinsurance joint venture are expected, which will be a headwind to adjusted EPS in 2025.

Risks

• Foreign Exchange: Headwinds from foreign exchange rates, particularly from sterling, euro, and Canadian dollar, which can impact financial results.
• Regulatory and Economic Uncertainties: Political and regulatory changes globally, as well as potential economic downturns, can affect client demand for services and impact revenue and margins.

Question and Answer

• Q: Thoughts on overall margin improvement and 2025 margin outlook?

A: Carl Hess and Andrew Krasner discussed that margins will be expanded through capturing benefits from the Transformation program, leveraging WE DO initiatives for efficiency, process optimization, and automation to support productivity gains.

• Q: Capital management and share repurchases?

A: Andrew Krasner explained that the $1.5 billion share repurchase plan is the baseline, subject to market conditions and potential investment in organic and inorganic opportunities aligned with strategy.

• Q: Free cash flow and reinsurance JV?

A: Andrew Krasner noted that free cash flow expectations include the sale of TRANZACT, wind down of transformation-related cash spending, and expected operating margin expansion, with reinsurance JV cash outflows sitting in the investing section of the cash flow statement.